CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Ribbon Biolabs has created a technology for synthesizing long DNA molecules, specifically targeting the production of modular genetic units for monoclonal antibody production. This approach aims to enhance production efficiency and reduce costs, making therapies more accessible.
Ribbon Biolabs has developed a unique, patented technology for the synthesis of long DNA molecules.
As a key product in development through this platform, the company is targeting at the development and production of small, chromosome-like synthetic modular genetic units - which we term MiChroms - for monoclonal antibody production.
The production of therapeutic monoclonal antibodies (mAbs) relies on unstable cell-lines, making the availability of the products limited and very expensive for the…
RIBBON BIOLABS GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
